|Articles|August 1, 2018
- Pharmaceutical Executive-08-01-2018
- Volume 38
- Issue 8
Pharmaceutical Executive, August 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Emerging Biotech: Innovation, Location, and Inspirationover 7 years ago
Cross-Border Funding in the Life Sciencesover 7 years ago
Face It. You’re Not a Biotech Anymoreover 7 years ago
The Pulse of Biopharma M&Aover 7 years ago
The Big Apple’s Fresh Start in Biotechover 7 years ago
‘Emerging’ Product Launch Strategiesover 7 years ago
Biotech Investment: Reigning in Spainover 7 years ago
Traditional Scientific Search is Brokenover 7 years ago
Tough Fight Looms in Preserving R&D Incentivesover 7 years ago
From Science to SuccessNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
2
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
3
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
4
Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
5